Why do people take part in atrial fibrillation screening? qualitative interview study in English primary care

Why do people take part in atrial fibrillation screening? qualitative interview study in English primary care

<p><strong>Objectives:</strong> There is insufficient evidence to support national screening programmes for atrial fibrillation (AF). Nevertheless, some practitioners, policy-makers and special interest groups have encouraged introduction of opportunistic screening in primary care...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Hoare, S, Powell, A, Modi, RN, Armstrong, N, Griffin, SJ, Mant, J, Burt, J, Hobbs, F
Kolejni autorzy:	SAFER Authorship Group
Format:	Journal article
Język:	English
Wydane:	BMJ Publishing Group 2022

Podobne zapisy

Why do people take part in atrial fibrillation screening? Qualitative interview study in English primary care
od: Richard Hobbs, i wsp.
Wydane: (2022-03-01)

Why do people choose not to take part in screening? Qualitative interview study of atrial fibrillation screening nonparticipation
od: Sarah Hoare, i wsp.
Wydane: (2023-12-01)

Randomised controlled trial of population screening for atrial fibrillation in people aged 70 years and over to reduce stroke: protocol for the SAFER trial
od: Mant, J, i wsp.
Wydane: (2024)

The feasibility of population screening for paroxysmal atrial fibrillation using hand-held electrocardiogram devices
od: Mant, J, i wsp.
Wydane: (2024)

Cluster randomised controlled trial of screening for atrial fibrillation in people aged 70 years and over to reduce stroke: protocol for the pilot study for the SAFER trial
od: Williams, K, i wsp.
Wydane: (2022)

Should we screen for atrial fibrillation?
od: Lown, M, i wsp.
Wydane: (2017)

Performance of stroke risk scores in older people with atrial fibrillation not taking warfarin: comparative cohort study from BAFTA trial.
od: Hobbs, F, i wsp.
Wydane: (2011)

Performance of stroke risk scores in older people with atrial fibrillation not taking warfarin: comparative cohort study from BAFTA trial
od: Hobbs, R, i wsp.
Wydane: (2011)

Is warfarin a safe alternative to aspirin in elderly patients with atrial fibrillation?
od: Mant, J, i wsp.
Wydane: (2008)

Warfarin versus aspirin for prevention of cognitive decline in atrial fibrillation: randomized controlled trial (Birmingham Atrial Fibrillation Treatment of the Aged Study).
od: Mavaddat, N, i wsp.
Wydane: (2014)

Effect of age on stroke prevention therapy in patients with atrial fibrillation: the atrial fibrillation investigators.
od: van Walraven, C, i wsp.
Wydane: (2009)

Response to letter regarding article, "warfarin versus aspirin for prevention of cognitive decline in atrial fibrillation: randomized controlled trial (birmingham atrial fibrillation treatment of the aged study)".
od: Mavaddat, N, i wsp.
Wydane: (2014)

Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial.
od: Mant, J, i wsp.
Wydane: (2007)

Accuracy of diagnosing atrial fibrillation on electrocardiogram by primary care practitioners and interpretative diagnostic software: analysis of data from screening for atrial fibrillation in the elderly (SAFE) trial.
od: Mant, J, i wsp.
Wydane: (2007)

A cross-sectional study of hypertension in an elderly population (75 years and over) with atrial fibrillation: secondary analysis of data from the Birmingham Atrial Fibrillation in the Aged (BAFTA) randomised controlled trial.
od: Hurley, V, i wsp.
Wydane: (2007)

Stroke prevention in atrial fibrillation
od: Hobbs, F
Wydane: (2003)

Cluster randomised controlled trial of screening for atrial fibrillation in people aged 70 years and over to reduce stroke: protocol for the pilot study for the SAFER trial
od: Martin R Cowie, i wsp.
Wydane: (2022-09-01)

Reliability of single-lead electrocardiogram interpretation to detect atrial fibrillation: insights from the SAFER feasibility study
od: Hibbitt, K, i wsp.
Wydane: (2024)

Reliability of single-lead electrocardiogram interpretation to detect atrial fibrillation: insights from the SAFER feasibility study
od: Hibbitt, K, i wsp.
Wydane: (2024)

Randomised controlled trial of population screening for atrial fibrillation in people aged 70 years and over to reduce stroke: protocol for the SAFER trial
od: Gregory Y H Lip, i wsp.
Wydane: (2024-04-01)

A cross-sectional study of quality of life in an elderly population (75 years and over) with atrial fibrillation: secondary analysis of data from the Birmingham Atrial Fibrillation Treatment of the Aged study.
od: Roalfe, A, i wsp.
Wydane: (2012)

Treatment pathways for patients with atrial fibrillation.
od: Hodgkinson, J, i wsp.
Wydane: (2012)

Paroxysmal atrial fibrillation (part II)
od: B. A. Tatarsky
Wydane: (2008-06-01)

Cost effectiveness of warfarin versus aspirin in patients older than 75 years with atrial fibrillation.
od: Jowett, S, i wsp.
Wydane: (2011)

Anticoagulant management in patients with atrial fibrillation.
od: Fitzmaurice, D, i wsp.
Wydane: (2009)

Atrial fibrillation and atrial flutter – the state of the art. Part 1
od: Agnieszka Janion-Sadowska, i wsp.
Wydane: (2021-06-01)

An analysis of factors that predict patient consent to take part in a randomized controlled trial.
od: Fletcher, K, i wsp.
Wydane: (2007)

Atrial fibrillation fact sheet in Korea 2024 (part 1): epidemiology of atrial fibrillation in Korea
od: So-Ryoung Lee, i wsp.
Wydane: (2024-07-01)

Impact of study design on recruitment of patients to a primary care trial: an observational time series analysis of the Birmingham Atrial Fibrillation Treatment of the Aged (BAFTA) study.
od: Fletcher, K, i wsp.
Wydane: (2010)

How to embed qualitative research in trials: insights from the feasibility study of the SAFER trial programme
od: Alison Powell, i wsp.
Wydane: (2022-05-01)

Paroxysmal forms of atrial fibrillation (part 1)
od: B. A. Tatarsky
Wydane: (2008-04-01)

Management of patients with atrial fibrillation at high risk of stroke: current treatment options
od: Edwards D, i wsp.
Wydane: (2012-06-01)

Protocol for Birmingham Atrial Fibrillation Treatment of the Aged study (BAFTA): a randomised controlled trial of warfarin versus aspirin for stroke prevention in the management of atrial fibrillation in an elderly primary care population [ISRCTN89345269]
od: Mant, J, i wsp.
Wydane: (2003)

Identification and treatment of patients with atrial fibrillation in primary care.
od: Hobbs, R
Wydane: (1999)

Randomised trial of two approaches to screening for atrial fibrillation in UK general practice.
od: Morgan, S, i wsp.
Wydane: (2002)

Rhythm control agents and adverse events in patients with atrial fibrillation.
od: Taylor, C, i wsp.
Wydane: (2010)

Atrial fibrillation fact sheet in Korea 2024 (part 3): treatment for atrial fibrillation in Korea: medicines and ablation
od: Yun Gi Kim, i wsp.
Wydane: (2024-08-01)

Atrial fibrillation fact sheet in Korea 2024: part 2—stroke prevention in Korean patients with atrial fibrillation
od: Pil-sung Yang, i wsp.
Wydane: (2024-08-01)

Nonvalvular atrial fibrillation and acute coronary syndrome: Present Indian perspective and assessment
od: Ranjan Modi, i wsp.
Wydane: (2021-01-01)

Research into practice: management of atrial fibrillation in general practice.
od: Fitzmaurice, D, i wsp.
Wydane: (2014)